Red Light Therapy Misconceptions vs. the Evidence

Red light therapy is surrounded by strong claims — both enthusiastic and skeptical. This article looks at seven common statements and compares each with information from regulators, international bodies, and published research. Some misconceptions overstate what light therapy can do; others misunderstand how it works. This article is informational only and does not recommend any treatment or device.

Misconception 1: "Red light therapy is the same as tanning or UV light"

The World Health Organization defines ultraviolet (UV) radiation as wavelengths from 100 to 400 nanometers, divided into UVA, UVB, and UVC bands.¹ UV exposure from sunlight and sunbeds is the primary cause of skin cancers, according to the WHO.¹ Red and near-infrared light have wavelengths longer than 400 nanometers, so they fall outside the UV range. They are a different part of the light spectrum from the UV radiation used in tanning beds.

This does not mean visible light carries no risk of any kind — see Misconception 6 on eye safety — but red LED light is not ultraviolet light.

Misconception 2: "FDA-cleared means FDA-approved and proven to work"

Most over-the-counter LED skin devices in the U.S. reach the market through the FDA's 510(k) process. In a 510(k), a manufacturer submits information intended to show that its device is as safe and effective as a legally marketed "predicate" device — that it is substantially equivalent. When the FDA agrees, it clears the device for marketing.²

"Cleared" and "approved" are different regulatory terms. Clearance reflects a comparison with an existing device; it does not mean the FDA approved the product or confirmed that it will produce a specific result for any user.

Misconception 3: "More light, or longer sessions, always means better results"

Researchers studying low-level light therapy have frequently observed what is called a biphasic dose response: in laboratory and animal studies, low levels of light often produced greater effects than higher levels, and in some experiments, very high doses reduced or reversed the effect.³ A review of this research noted that the complexity of choosing among parameters such as wavelength, power density, and treatment timing has contributed to both positive and negative published studies.³

Much of this evidence comes from cell and animal studies, and the optimal parameters for human skin have not been established. A 2018 systematic review of LED trials stated that it was difficult to determine an optimal power density or dose because study parameters varied so widely.⁴

Misconception 4: "Red light therapy is proven for every skin concern"

The strength of evidence varies considerably by condition. A 2018 systematic review of 31 randomized controlled trials of LED devices in dermatology graded the evidence by condition: acne, herpes simplex and zoster, and acute wound healing received grade B; skin rejuvenation and psoriasis received grade C; and several other conditions received grade D.⁴

Even for acne, a 2016 Cochrane review of light therapies concluded that "high-quality evidence on the use of light therapies for people with acne is lacking,"⁵ and the American Academy of Dermatology's 2024 acne guidelines found insufficient evidence to make a recommendation on laser and light-based devices.⁶

Misconception 5: "Red light therapy causes cancer"

A 2023 systematic review examined the oncologic safety of red and near-infrared light (625–1100 nm) for aesthetic skin rejuvenation, covering 57 laboratory, animal, and clinical studies. The author concluded that current evidence suggests it is oncologically safe for skin rejuvenation, while noting that the clinical evidence comes mainly from small, single-center studies and that no large multicenter randomized trials exist.⁷ Separately, as described under Misconception 1, red and near-infrared light are not UV radiation, which the WHO identifies as the primary cause of skin cancers.¹

Misconception 6: "Any LED mask is harmless to the eyes"

In 2019, a blue-light acne mask sold by Neutrogena was recalled. Australia's Therapeutic Goods Administration stated that people with certain eye conditions, such as retinitis pigmentosa or ocular albinism, or those taking medications that increase the eyes' sensitivity to light, could face a risk of retinal damage, and it advised all users to stop using the product.⁸ In January 2026, the French government's public health information service also highlighted eye-safety concerns specific to blue-light masks.⁹ Eye-safety considerations depend on the device, its wavelengths, and the individual.

Misconception 7: "Results are immediate" — or — "Light therapy does nothing at all"

Both extremes are inconsistent with the published research. Clinical trials of LED devices for skin have typically assessed participants after several weeks of repeated treatments rather than after a single session,⁴ and the French public health service noted that reported effects take time to appear and that their durability is unknown.⁹ At the same time, several randomized trials and meta-analyses have reported measurable changes compared with control groups for some conditions,^4,5 though reviewers consistently note small sample sizes and inconsistent methods.

Summary

The research on red light therapy supports neither the most enthusiastic marketing claims nor blanket dismissal. Evidence quality varies by condition, optimal parameters are not established, regulatory clearance is not proof of effectiveness, and eye safety depends on the device and the person. Many open questions remain that larger, longer, independent studies could help answer.

Disclaimer

This article is for general informational purposes only and does not constitute medical, legal, or professional advice. It summarizes publicly available information and published research and is not intended to diagnose, treat, cure, or prevent any condition, or to suggest that any device will produce a particular result. Regulatory clearance of a device does not guarantee its safety or effectiveness. Redlight Ratings is not a medical provider. Anyone with health questions should consult a qualified healthcare professional.

References

1. World Health Organization. Ultraviolet radiation (health topic and fact sheet). https://www.who.int/health-topics/ultraviolet-radiation; https://www.who.int/news-room/fact-sheets/detail/ultraviolet-radiation
2. U.S. Food and Drug Administration. Premarket Notification 510(k). https://www.fda.gov/medical-devices/premarket-submissions-selecting-and-preparing-correct-submission/premarket-notification-510k
3. Huang YY, Chen AC, Carroll JD, Hamblin MR. Biphasic dose response in low level light therapy. Dose-Response. 2009;7(4):358-383. https://pmc.ncbi.nlm.nih.gov/articles/PMC2790317/
4. Jagdeo J, Austin E, Mamalis A, Wong C, Ho D, Siegel DM. Light-emitting diodes in dermatology: A systematic review of randomized controlled trials. Lasers in Surgery and Medicine. 2018;50(6):613-628. https://pmc.ncbi.nlm.nih.gov/articles/PMC6099480/
5. Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne. Cochrane Database of Systematic Reviews. 2016;9(9):CD007917. https://pubmed.ncbi.nlm.nih.gov/27670126/
6. Reynolds RV, Yeung H, Cheng CE, et al. Guidelines of care for the management of acne vulgaris. Journal of the American Academy of Dermatology. 2024;90(5):1006.e1-1006.e30. https://doi.org/10.1016/j.jaad.2023.12.017
7. Glass GE. Photobiomodulation: A systematic review of the oncologic safety of low-level light therapy for aesthetic skin rejuvenation. Aesthetic Surgery Journal. 2023;43(5):NP357-NP371. https://pmc.ncbi.nlm.nih.gov/articles/PMC10309024/
8. Therapeutic Goods Administration (Australia). Neutrogena Visibly Clear Light Therapy Acne Mask and Activator — product recall. 2019. https://www.tga.gov.au/news/product-recalls/neutrogena-visibly-clear-light-therapy-acne-mask-and-activator
9. Santé.fr (Service Public d'Information en Santé, France). Les masques à LED sont-ils efficaces et sûrs ? January 12, 2026. https://www.sante.fr/node/8069061